小蓝鸟pvn– 官网网址入口
We are currently recruiting for the Phase 3 study of MDMA-assisted psychotherapy for PTSD. Here is a list of all MAPS-sponsored trials on clinicaltrials.gov.
MAPS PBC is a wholly-owned subsidiary of the Multidisciplinary Association for Psychedelic Studies (MAPS). MAPS is a 501(c)(3) non-profit research and educational organization that develops medical, legal, and cultural contexts for people to benefit from the careful uses of psychedelics and marijuana.
小蓝鸟pvn– 官网网址入口
小蓝鸟pvn– 官网网址入口
June 10, 2024 小蓝鸟pvn– 官网网址入口
June 3, 2024 小蓝鸟pvn– 官网网址入口
May 16, 2024 小蓝鸟pvn– 官网网址入口
May 10, 2024 小蓝鸟pvn– 官网网址入口
The Lancet: Psychiatry
MDMA-assisted psychotherapy for PTSD in military veterans, firefighters, and police officers: a randomised, double-blind, dose-response, phase 2 clinical trial.
Psychopharmacology: Pooled CAPS Study
Here we evaluate six phase 2 trials in a pooled analysis to determine the study design for phase 3 trials of MDMA-assisted psychotherapy for PTSD. MDMA-assisted psychotherapy was efficacious and well tolerated in a large sample of adults with PTSD.
什么加速器可众看油管
Learn more about all of our completed, ongoing and planned studies, and see all of our publications on our Study Information page.